Boehringer Ingelheim and Cue Biopharma, announced a strategic research collaboration and license agreement to develop and commercialize Cue Biopharma’s CUE-501 product candidate, a differentiated B...
INmune Bio a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune system has partnered with the Cell and Gene Therapy Catapult...
Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, focused on the development of oncology, immunology, and critical care therapies, announced that Intas Pharmaceuticals...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Calidi Biotherapeutics, a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, announced the appointment of Guy Travis Clifton, MD as Chief...
